Dudediligence.

Fortress Biotech, Inc

FBIONASDAQ · Pharmaceutical Preparations
Write an idea

Fundamentals

Oldest to newest
Revenue, by quarter
$14.6MSep ’24$12.6MDec ’24$13.1MMar ’25$15.0MJun ’25$17.0MSep ’25$16.1MDec ’25$15.9MMar ’26$17.8MJun ’26
Net income, by quarter
−$12.9MSep ’24−$6.8MDec ’24−$10.6MMar ’25$15.5MJun ’25$5.8MSep ’25$26.2MDec ’25$110.4MMar ’26−$468,000Jun ’26
Fiscal years, by the month each ended
LineDec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Revenue$63.1M$71.0M$59.7M$55.1M$61.2M
Gross profit$31.1M$40.2M$36.8M$34.3M$40.3M
Operating income−$188.5M−$203.6M−$142.3M−$110.4M−$70.2M
Net income−$64.7M−$86.6M−$60.6M−$46.0M$37.0M
Operating cash flow−$116.5M−$179.4M−$128.2M−$80.2M−$65.8M
Free cash flow−$121.1M−$182.1M−$128.3M−$80.2Mnone on file
Cash$305.7M$178.3M$80.9M$57.3M$79.4M
Debt$42.9M$91.7M$60.9M$58.0M$54.5M
Shares outstanding101.4M7.4M15.1M27.9M31.4M